PHLEBOTOMY DEPENDENT POLYCYTHEMIA VERA

Clinical trials for PHLEBOTOMY DEPENDENT POLYCYTHEMIA VERA explained in plain language.

Never miss a new study

Get alerted when new PHLEBOTOMY DEPENDENT POLYCYTHEMIA VERA trials appear

Sign up with your email to follow new studies for PHLEBOTOMY DEPENDENT POLYCYTHEMIA VERA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 1

New drug aims to free patients from frequent blood draws

Disease control Ongoing

This study is testing an investigational drug called sapablursen to see if it can reduce the need for frequent therapeutic blood draws (phlebotomy) in people with polycythemia vera. About 50 participants will receive injections under the skin for about 8 months to see if the trea…

Matched conditions: PHLEBOTOMY DEPENDENT POLYCYTHEMIA VERA

Phase: PHASE2 • Sponsor: Ionis Pharmaceuticals, Inc. • Aim: Disease control

Last updated Apr 02, 2026 14:57 UTC

PHLEBOTOMY DEPENDENT POLYCYTHEMIA VERA

Get alerted when new PHLEBOTOMY DEPENDENT POLYCYTHEMIA VERA trials appear

New drug aims to free patients from frequent blood draws